flufenamic acid has been researched along with Experimental Neoplasms in 3 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grinwich, KD | 1 |
| Plescia, OJ | 2 |
| Grinwich, K | 1 |
| Plescia, AM | 1 |
| Davidova, SY | 1 |
| Shapot, VS | 1 |
| Drozdova, GA | 1 |
3 other studies available for flufenamic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis.
Topics: Animals; Antibody Formation; Aspirin; Cell Line; Erythrocytes; Flufenamic Acid; Immunosuppression Th | 1977 |
Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins.
Topics: Animals; Antibodies, Neoplasm; Flufenamic Acid; Graft Rejection; Immunity, Cellular; Immunosuppressi | 1976 |
On the heterogeneity of catalase in rat liver and experimental hepatomas of rats and mice.
Topics: Alcohols; Animals; Bile Acids and Salts; Carcinoma, Hepatocellular; Catalase; Cell Membrane; Female; | 1970 |